LA
KURA icon

Legacy Advisors’s Kura Oncology KURA Stock Holding History

Legacy Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,900
Closed -$77K – 225
2019
Q2 		$77K Hold
3,900
– – 0.05% 177
2019
Q1 		$65K Buy
+3,900
New +$60.1K 0.02% 194
2018
Q4 		– Sell
-3,900
Closed -$68K – 260
2018
Q3 		$68K Hold
3,900
– – 0.03% 204
2018
Q2 		$71K Hold
3,900
– – 0.05% 161
2018
Q1 		$68K Hold
3,900
– – 0.05% 138
2017
Q4 		$59K Hold
3,900
– – 0.06% 123
2017
Q3 		$58K Buy
+3,900
New +$36.6K 0.06% 102

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Legacy Advisors's KURA Position: Q3 2019 in Review

Legacy Advisors sold out of Kura Oncology (KURA) in Q3 2019, closing a stake of 3,900 shares — an estimated $77K sold.

Legacy Advisors first reported a position in KURA in Q3 2017 and held it in 7 quarters. The position peaked at $77K in Q2 2019. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • Legacy Advisors reported no remaining Kura Oncology position as of Q3 2019 after selling out during the quarter.
  • Legacy Advisors sold 3,900 Kura Oncology shares in Q3 2019, an estimated $77K.
  • Legacy Advisors first reported a position in Kura Oncology in Q3 2017 and held it in 7 quarters.
  • Legacy Advisors's Kura Oncology position peaked at $77K in Q2 2019.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on Legacy Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.